{"id":36930,"date":"2025-11-12T00:54:37","date_gmt":"2025-11-12T00:54:37","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=36930"},"modified":"2025-11-12T00:54:51","modified_gmt":"2025-11-12T00:54:51","slug":"nextsense-secures-16-million-to-launch-wireless-eeg-smartbuds-for-brain-health","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/nextsense-secures-16-million-to-launch-wireless-eeg-smartbuds-for-brain-health\/","title":{"rendered":"NextSense Secures $16 Million to Launch Wireless EEG Smartbuds for Brain Health"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/g-medtech.com\/database\/medtech-players\/index\/nextsense\/\" target=\"_blank\" rel=\"noreferrer noopener\">NextSense<\/a>, a Mountain View\u2013based neurotechnology company, has closed a $16 million Series A funding round to accelerate the launch of its Smartbuds \u2014 wireless earbuds equipped with EEG sensors capable of tracking brain activity. The oversubscribed round was led by Ascension Ventures, with additional participation from Satori Neuro, Corundrum Neuroscience Fund, and individual investors including Stanford neuroscientist David Eagleman, Wellville founder Esther Dyson, and former Google executive Bradley Horowitz.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Founder and CEO Jonathan Berent said the company\u2019s mission is to make brain health as accessible as physical fitness tracking. \u201cWe started NextSense to democratize brain health \u2014 to give people the same visibility into their minds that wearables gave their bodies,\u201d he said. \u201cThis round is the next step toward that reality.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Smartbuds are expected to launch in the fourth quarter of 2025, offering clinically validated sleep monitoring and adaptive audio designed to enhance deep sleep. The earbuds use EEG sensors and real-time algorithms to deliver personalized soundscapes that help users relax, focus, and achieve more restorative rest. Early trials have shown auditory stimulation can increase slow-wave sleep by up to 50%.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lead investor John Kuelper of Ascension Ventures said the firm backed NextSense for its ability to \u201ctranslate decades of neuroscience into accessible, consumer-ready solutions.\u201d Other investors echoed similar confidence, noting the company\u2019s potential to bridge neuroscience research with everyday wellness.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">NextSense plans to expand its technology through partnerships with universities and pharmaceutical firms, with medical-grade applications targeted for 2027. The company\u2019s vision, supported by strong investor enthusiasm, is to pioneer a new generation of wearables that not only monitor brain activity but actively improve cognitive and emotional well-being. Smartbuds are now available for pre-order and will begin shipping later next year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>California-based NextSense has raised $16 million in Series A funding led by Ascension Ventures to launch its wireless EEG-enabled Smartbuds, aiming to bring clinically accurate sleep and brain health tracking to consumers in 2025.<\/p>\n","protected":false},"author":2,"featured_media":36931,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[7,488,681,10],"tags":[594],"class_list":["post-36930","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas","category-breaking-news","category-care-therapy","category-strategic-development","tag-financing"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/36930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=36930"}],"version-history":[{"count":1,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/36930\/revisions"}],"predecessor-version":[{"id":36932,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/36930\/revisions\/36932"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/36931"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=36930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=36930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=36930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}